Αποτελέσματα Αναζήτησης
1 Ιαν 2018 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 ...
- Updated recommendations on HIV prevention, infant diagnosis ...
March 2021: These guidelines provide new and updated...
- Updated recommendations on HIV prevention, infant diagnosis ...
18 Ιουλ 2022 · Safe and effective paediatric formulations of the most promising antiretroviral drugs are crucial to advance the treatment and prevention of HIV in neonates, infants, children, and adolescents.
27 Ιουν 2024 · Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.
27 Ιουν 2024 · For infants and children initiating treatment for HIV for the first time, the Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV recommends initiating antiretroviral treatment (ART) with three drugs: a dual–nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) backbone plus an integrase strand transfer ...
27 Ιουν 2024 · The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has reviewed and updated text and references of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection last published on April 11, 2023. Key updates are summarized below.
Children. 4. For children between 12 and 24 months of age exposed to maternal or infant NVP or other NNRTIs used for maternal treatment or PMTCT, start ART with lopinavir/ritonavir (LPV/r) + 2 NRTIs. (Conditional recommendation, low quality of evidence) 5.
17 Μαρ 2021 · March 2021: These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for ...
